Viking Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
CEOBrian Lian
CEOBrian Lian
Employees36
Employees36
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees36
Employees36
VKTX Key Statistics
Market cap2.66B
Market cap2.66B
Price-Earnings ratio-15.44
Price-Earnings ratio-15.44
Dividend yield—
Dividend yield—
Average volume5.01M
Average volume5.01M
High today$24.20
High today$24.20
Low today$23.53
Low today$23.53
Open price$24.13
Open price$24.13
Volume4.29M
Volume4.29M
52 Week high$81.73
52 Week high$81.73
52 Week low$18.92
52 Week low$18.92
VKTX News
Simply Wall St 6d
Viking Therapeutics Valuation: Are Investors Paying Too Much for Future Growth?Advertisement What’s Behind Viking Therapeutics' Recent Moves? If you hold shares of Viking Therapeutics (VKTX) or are thinking about jumping in, the stock’s...
Analyst ratings
94%
of 16 ratingsBuy
93.8%
Hold
6.3%
Sell
0%
People also own
Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.